NDC 0310-6616 – Breztri
Budesonide 160 ug/1; Glycopyrrolate 18 ug/1; Formoterol 4.8 ug/1 · Aerosol, Metered · Respiratory (inhalation)
Product NDC0310-6616
Product details
- Brand name
- Breztri
- Generic name
- Budesonide, glycopyrrolate, and formoterol fumarate
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- Aerosol, Metered
- Route
- Respiratory (inhalation)
- Marketing category
- NDA · NDA212122
- Marketed since
- April 27, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist; Corticosteroid; beta2-Adrenergic Agonist
Active ingredients
- Budesonide 160 ug/1
- Glycopyrrolate 18 ug/1
- Formoterol 4.8 ug/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0310-6616-01 | 120 AEROSOL, METERED in 1 INHALER (0310-6616-01) | Apr 27, 2026 |
| 0310-6616-39 | 28 AEROSOL, METERED in 1 INHALER (0310-6616-39) | Apr 27, 2026 |
| 0310-6616-95 sample | 28 AEROSOL, METERED in 1 INHALER (0310-6616-95) | Apr 27, 2026 |
Other Breztri products
- 0310-4616 Budesonide 160 ug/1; Glycopyrrolate 9 ug/1; Formoterol 4.8 ug/1 · Aerosol, Metered · AstraZeneca Pharmaceuticals LP